StockData
Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Inc. (FHTX) stock

FHTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/30
$1.83+0.04 (+2.23%)

Close on Nov 17, 2026Market cap $108.68MP/E –Yield –

Foghorn Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Foghorn Therapeutics's price to sales ratio was 3.3× on Nov 11, 2026, against 11.0× a year earlier. Over the last 5 years it ranged from 3.3× to 480.9×, with a median of 11.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.3×−9.1
2025Dec 31, 202512.5×+2.2
2024Dec 31, 202410.3×+1.9
2023Dec 29, 20238.4×−8.6
2022Dec 30, 202216.9×−453.2
2021Oct 29, 2021470.1×–

More Foghorn Therapeutics figures

See a number that looks wrong?